What we know so far: COVID-19 current clinical knowledge and research.

Tytuł:: What we know so far: COVID-19 current clinical knowledge and research.
Autorzy:: Lake MA; University of Cambridge, Cambridge, UK .
Źródło:: Clinical medicine (London, England) [Clin Med (Lond)] 2020 Mar; Vol. 20 (2), pp. 124-127. Date of Electronic Publication: 2020 Mar 05.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Original Publication: London : The College, c2001-
MeSH Terms:: Coronavirus Infections*/diagnosis
Coronavirus Infections*/epidemiology
Coronavirus Infections*/therapy
Coronavirus Infections*/transmission
Disease Outbreaks*
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/therapy
Pneumonia, Viral*/transmission
Public Health Surveillance*
Betacoronavirus ; COVID-19 ; Humans ; Palliative Care ; Public Health ; SARS-CoV-2 ; Severe Acute Respiratory Syndrome/epidemiology
References:: Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
N Engl J Med. 2020 Mar 26;382(13):1199-1207. (PMID: 31995857)
J Med Virol. 2020 Apr;92(4):433-440. (PMID: 31967321)
N Engl J Med. 2020 Mar 5;382(10):929-936. (PMID: 32004427)
BMC Infect Dis. 2014 Sep 04;14:480. (PMID: 25186370)
Nat Commun. 2020 Jan 10;11(1):222. (PMID: 31924756)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Lancet Infect Dis. 2017 Dec;17(12):e420-e428. (PMID: 28757186)
Clin Infect Dis. 2004 Sep 1;39(5):652-7. (PMID: 15356778)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
Nature. 2020 Jan 23;:. (PMID: 33479530)
N Engl J Med. 2020 Mar 5;382(10):970-971. (PMID: 32003551)
J Infect Dis. 2005 May 1;191(9):1472-7. (PMID: 15809906)
Lancet. 2020 Feb 15;395(10223):514-523. (PMID: 31986261)
PLoS One. 2017 Jul 20;12(7):e0181558. (PMID: 28727803)
Science. 2003 Oct 10;302(5643):276-8. (PMID: 12958366)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
PLoS Med. 2006 Sep;3(9):e343. (PMID: 16968120)
N Engl J Med. 2020 Feb 27;382(9):872-874. (PMID: 31991079)
Contributed Indexing:: Keywords: 2019-nCoV; SARS-CoV-2; Wuhan; coronavirus; respiratory tract infection
Entry Date(s):: Date Created: 20200307 Date Completed: 20200323 Latest Revision: 20231113
Update Code:: 20240105
PubMed Central ID:: PMC7081812
DOI:: 10.7861/clinmed.2019-coron
PMID:: 32139372
: Czasopismo naukowe

Pełny tekst

In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.
(© Royal College of Physicians 2020. All rights reserved.)

Comment in: Oral Dis. 2022 Apr;28 Suppl 1:935-936. (PMID: 32558983)
Comment in: J Craniofac Surg. 2020 Sep;31(6):e658-e660. (PMID: 32796315)

Informacja